^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Besremi (ropeginterferon alfa-2b-njft)

    i
    Other names: P-1101, AOP-2014, peg-IFN alpha-2b, PEG-P-IFN-alpha-2b, peg-IFN-alpha-2b, AOP2014, AOP 2014, P1101, PEG-proline-interferon alpha-2b, ropeg, KKP-1101, KKP1101, KKP 1101
    Associations
    News
    Trials
    Company:
    AOP Orphan Pharma, PharmaEssentia, Pint Pharma
    Drug class:
    IFNα 2b stimulant
    Related drugs:
    Associations
    News
    Trials